PMC:7091888 / 1245-1517 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"50","span":{"begin":38,"end":48},"obj":"Species"},{"id":"51","span":{"begin":86,"end":94},"obj":"Species"},{"id":"52","span":{"begin":132,"end":142},"obj":"Species"},{"id":"57","span":{"begin":147,"end":165},"obj":"Disease"},{"id":"92","span":{"begin":205,"end":210},"obj":"Species"},{"id":"93","span":{"begin":211,"end":224},"obj":"Species"},{"id":"94","span":{"begin":226,"end":230},"obj":"Species"}],"attributes":[{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"Tax:2697049"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"Tax:694009"},{"id":"A52","pred":"tao:has_database_id","subj":"52","obj":"Tax:2697049"},{"id":"A57","pred":"tao:has_database_id","subj":"57","obj":"MESH:C000657245"},{"id":"A92","pred":"tao:has_database_id","subj":"92","obj":"Tax:9606"},{"id":"A93","pred":"tao:has_database_id","subj":"93","obj":"Tax:11118"},{"id":"A94","pred":"tao:has_database_id","subj":"94","obj":"Tax:11118"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"duced antisera could cross-neutralize SARS-CoV-2, suggesting the potential to develop SARS-CoV RBD-based vaccines for prevention of SARS-CoV-2 and SARS-CoV infection.\n\nIntroduction\nThree highly pathogenic human coronaviruses (CoVs) have been identified so far, including M"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T25","span":{"begin":38,"end":46},"obj":"Disease"},{"id":"T26","span":{"begin":38,"end":42},"obj":"Disease"},{"id":"T27","span":{"begin":86,"end":94},"obj":"Disease"},{"id":"T28","span":{"begin":86,"end":90},"obj":"Disease"},{"id":"T29","span":{"begin":132,"end":140},"obj":"Disease"},{"id":"T30","span":{"begin":132,"end":136},"obj":"Disease"},{"id":"T31","span":{"begin":147,"end":165},"obj":"Disease"},{"id":"T32","span":{"begin":147,"end":151},"obj":"Disease"},{"id":"T33","span":{"begin":156,"end":165},"obj":"Disease"}],"attributes":[{"id":"A25","pred":"mondo_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A27","pred":"mondo_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A28","pred":"mondo_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A29","pred":"mondo_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A33","pred":"mondo_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"duced antisera could cross-neutralize SARS-CoV-2, suggesting the potential to develop SARS-CoV RBD-based vaccines for prevention of SARS-CoV-2 and SARS-CoV infection.\n\nIntroduction\nThree highly pathogenic human coronaviruses (CoVs) have been identified so far, including M"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T9","span":{"begin":205,"end":210},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"duced antisera could cross-neutralize SARS-CoV-2, suggesting the potential to develop SARS-CoV RBD-based vaccines for prevention of SARS-CoV-2 and SARS-CoV infection.\n\nIntroduction\nThree highly pathogenic human coronaviruses (CoVs) have been identified so far, including M"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":168,"end":180},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"duced antisera could cross-neutralize SARS-CoV-2, suggesting the potential to develop SARS-CoV RBD-based vaccines for prevention of SARS-CoV-2 and SARS-CoV infection.\n\nIntroduction\nThree highly pathogenic human coronaviruses (CoVs) have been identified so far, including M"}